Logo
x

Search category

Subscribe Now

Biostar Pharma

Biostar Pharma’s Utidelone Injectable Receives the USFDA’s Orphan Drug Designation for Treating Breast Cancer Brain Metastasis

Biostar Pharma’s Utidelone Injectable Receives the USFDA’s Orphan Drug Designation for Treating Breast Cancer Brain Metastasis

  • April 1, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.